Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 1Surgery 1Stress, Psychological 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Multiple Myeloma 1Medulloblastoma 1Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Intermittent Fasting 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Cancer Invasive 1

Interventions

Cyclophosphamide 3fludarabine 2Paclitaxel 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1pembrolizumab 1olaparib 1niraparib 1mirvetuximab soravtansine 1irinotecan sucrosofate 1fludarabine phosphate 1denileukin diftitox 1Tinzaparin 1Propranolol 1Palliative Care 1Nivolumab 1Neoadjuvant Therapy 1Music Therapy 1Losartan 1Indocyanine Green 1GEN-1 1Etodolac 1E7777 fusion protein 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Neoadjuvant Therapy × 30 days × Clear all
NCT06386887 2026-05-07

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Case Comprehensive Cancer Center

Phase NA Recruiting
20 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Intermittent Fasting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡